Deutsche Bank
DFTX icon

Deutsche Bank’s Definium Therapeutics DFTX Stock Holding History

Deutsche Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.51M Buy
144,657
+1,710
+1% +$72.1K ﹤0.01% 1198
2026
Q2 		$6.72M Sell
142,947
-268,887
-65% -$6.64M ﹤0.01% 1219
2026
Q1 		$7.78M Buy
411,834
+13,565
+3% +$230K ﹤0.01% 1135
2025
Q4 		$5.33M Buy
398,269
+343,109
+622% +$4.25M ﹤0.01% 1275
2025
Q3 		$650K Buy
55,160
+7,171
+15% +$66.9K ﹤0.01% 2417
2025
Q2 		$311K Sell
47,989
-11,237
-19% -$73.9K ﹤0.01% 2709
2025
Q1 		$346K Sell
59,226
-12,369
-17% -$88.6K ﹤0.01% 2676
2024
Q4 		$498K Buy
71,595
+24,716
+53% +$170K ﹤0.01% 2614
2024
Q3 		$267K Buy
46,879
+10,189
+28% +$70.9K ﹤0.01% 2775
2024
Q2 		$265K Buy
36,690
+31,077
+554% +$272K ﹤0.01% 2662
2024
Q1 		$52.8K Hold
5,613
– – ﹤0.01% 3382
2023
Q4 		$20.5K Hold
5,613
– – ﹤0.01% 3489
2023
Q3 		$17.6K Hold
5,613
– – ﹤0.01% 3518
2023
Q2 		$20K Sell
5,613
-2,408
-30% -$8.31K ﹤0.01% 3583
2023
Q1 		$25.4K Sell
8,021
-2,368
-23% -$7.87K ﹤0.01% 3686
2022
Q4 		$22.9K Hold
10,389
– – ﹤0.01% 3754
2022
Q3 		$37K Sell
10,389
-1,513
-13% -$14.5K ﹤0.01% 3667
2022
Q2 		$115K Sell
11,902
-12,517
-51% -$158K ﹤0.01% 3458
2022
Q1 		$406K Buy
24,419
+2,304
+10% +$40K ﹤0.01% 2873
2021
Q4 		$458K Buy
22,115
+1,140
+5% +$36.4K ﹤0.01% 2904
2021
Q3 		$732K Buy
20,975
+1,713
+9% +$74.1K ﹤0.01% 2805
2021
Q2 		$997K Buy
+19,262
New +$1.01M ﹤0.01% 2771

Other funds holding DFTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

Deutsche Bank's DFTX Position: Q3 2026 in Review

Deutsche Bank increased its Definium Therapeutics (DFTX) stake by 1.2% in Q3 2026, buying an estimated $72.1K and bringing the position to 144,657 shares worth $5.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Deutsche Bank first reported a position in DFTX in Q2 2021 and has held it in 22 quarters since. The position peaked at $7.78M in Q1 2026. 125 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Deutsche Bank held 144,657 shares of Definium Therapeutics worth $5.51M as of Q3 2026.
  • Deutsche Bank bought 1,710 Definium Therapeutics shares in Q3 2026, an estimated $72.1K.
  • Definium Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1198 holding.
  • Deutsche Bank first reported a position in Definium Therapeutics in Q2 2021 and has held it in 22 quarters since.
  • Deutsche Bank's Definium Therapeutics position peaked at $7.78M in Q1 2026.
  • 125 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.